APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arthritis Treatment Medicine for Dogs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Arthritis Treatment Medicine for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025181 pages

Choose your research edition.

Industry ResearchArthritis Treatment Medicine for Dogs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Arthritis Treatment Medicine for Dogs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Arthritis Treatment Medicine for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arthritis Treatment Medicine for Dogs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Arthritis Treatment Medicine for Dogs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Arthritis Treatment Medicine for Dogs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Arthritis Treatment Medicine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Arthritis Treatment Medicine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arthritis Treatment Medicine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Arthritis Treatment Medicine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arthritis Treatment Medicine for Dogs include Bayer, Zoetis, VetStem, Vetoquinol, Norbrook Laboratories, Elanco, Dechra Pharmaceuticals and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Arthritis Treatment Medicine for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Arthritis Treatment Medicine for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arthritis Treatment Medicine for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arthritis Treatment Medicine for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.

Arthritis Treatment Medicine for Dogs Segment by Company

Bayer

Zoetis

VetStem

Vetoquinol

Norbrook Laboratories

Elanco

Dechra Pharmaceuticals

Boehringer Ingelheim

Arthritis Treatment Medicine for Dogs Segment by Type

Non-Steroidal Anti-Inflammatory Drug

Opioids

Others

Arthritis Treatment Medicine for Dogs Segment by Application

Hospital and Clinic

Retail

Arthritis Treatment Medicine for Dogs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arthritis Treatment Medicine for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arthritis Treatment Medicine for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arthritis Treatment Medicine for Dogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Arthritis Treatment Medicine for Dogs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arthritis Treatment Medicine for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Arthritis Treatment Medicine for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Arthritis Treatment Medicine for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Arthritis Treatment Medicine for Dogs Industry Trends Table 2. Arthritis Treatment Medicine for Dogs Industry Drivers Table 3. Arthritis Treatment Medicine for Dogs Industry Opportunities and Challenges Table 4. Arthritis Treatment Medicine for Dogs Industry Restraints Table 5. Global Arthritis Treatment Medicine for Dogs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Arthritis Treatment Medicine for Dogs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Manufacturers Table 9. Global Arthritis Treatment Medicine for Dogs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Arthritis Treatment Medicine for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Arthritis Treatment Medicine for Dogs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Arthritis Treatment Medicine for Dogs Manufacturers, Product Type & Application Table 13. Global Arthritis Treatment Medicine for Dogs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Arthritis Treatment Medicine for Dogs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non-Steroidal Anti-Inflammatory Drug Table 17. Major Manufacturers of Opioids Table 18. Major Manufacturers of Others Table 19. Global Arthritis Treatment Medicine for Dogs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Arthritis Treatment Medicine for Dogs Sales by Type (2021-2026) & (K Units) Table 21. Global Arthritis Treatment Medicine for Dogs Sales by Type (2027-2032) & (K Units) Table 22. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Type (2021-2026) Table 23. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Type (2027-2032) Table 24. Global Arthritis Treatment Medicine for Dogs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Arthritis Treatment Medicine for Dogs Revenue by Type (2021-2026) & (K Units) Table 26. Global Arthritis Treatment Medicine for Dogs Revenue by Type (2027-2032) & (K Units) Table 27. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Type (2021-2026) Table 28. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital and Clinic Table 30. Major Manufacturers of Retail Table 31. Global Arthritis Treatment Medicine for Dogs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Arthritis Treatment Medicine for Dogs Sales by Application (2021-2026) & (K Units) Table 33. Global Arthritis Treatment Medicine for Dogs Sales by Application (2027-2032) & (K Units) Table 34. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Application (2021-2026) Table 35. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Application (2027-2032) Table 36. Global Arthritis Treatment Medicine for Dogs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Arthritis Treatment Medicine for Dogs Revenue by Application (2021-2026) & (K Units) Table 38. Global Arthritis Treatment Medicine for Dogs Revenue by Application (2027-2032) & (K Units) Table 39. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Application (2021-2026) Table 40. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Application (2027-2032) Table 41. Global Arthritis Treatment Medicine for Dogs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Arthritis Treatment Medicine for Dogs Sales by Region (2021-2026) & (K Units) Table 43. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Region (2021-2026) Table 44. Global Arthritis Treatment Medicine for Dogs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Arthritis Treatment Medicine for Dogs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Arthritis Treatment Medicine for Dogs Sales by Country (2021-2026) & (K Units) Table 48. North America Arthritis Treatment Medicine for Dogs Sales by Country (2027-2032) & (K Units) Table 49. Europe Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Arthritis Treatment Medicine for Dogs Sales by Country (2021-2026) & (K Units) Table 51. Europe Arthritis Treatment Medicine for Dogs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Arthritis Treatment Medicine for Dogs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Arthritis Treatment Medicine for Dogs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales by Country (2027-2032) & (K Units) Table 58. Global Arthritis Treatment Medicine for Dogs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Arthritis Treatment Medicine for Dogs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Arthritis Treatment Medicine for Dogs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Region (2021-2026) Table 62. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Region (2027-2032) Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer Arthritis Treatment Medicine for Dogs Product Portfolio Table 67. Bayer Recent Development Table 68. Zoetis Company Information Table 69. Zoetis Business Overview Table 70. Zoetis Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zoetis Arthritis Treatment Medicine for Dogs Product Portfolio Table 72. Zoetis Recent Development Table 73. VetStem Company Information Table 74. VetStem Business Overview Table 75. VetStem Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. VetStem Arthritis Treatment Medicine for Dogs Product Portfolio Table 77. VetStem Recent Development Table 78. Vetoquinol Company Information Table 79. Vetoquinol Business Overview Table 80. Vetoquinol Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Vetoquinol Arthritis Treatment Medicine for Dogs Product Portfolio Table 82. Vetoquinol Recent Development Table 83. Norbrook Laboratories Company Information Table 84. Norbrook Laboratories Business Overview Table 85. Norbrook Laboratories Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Norbrook Laboratories Arthritis Treatment Medicine for Dogs Product Portfolio Table 87. Norbrook Laboratories Recent Development Table 88. Elanco Company Information Table 89. Elanco Business Overview Table 90. Elanco Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Elanco Arthritis Treatment Medicine for Dogs Product Portfolio Table 92. Elanco Recent Development Table 93. Dechra Pharmaceuticals Company Information Table 94. Dechra Pharmaceuticals Business Overview Table 95. Dechra Pharmaceuticals Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Dechra Pharmaceuticals Arthritis Treatment Medicine for Dogs Product Portfolio Table 97. Dechra Pharmaceuticals Recent Development Table 98. Boehringer Ingelheim Company Information Table 99. Boehringer Ingelheim Business Overview Table 100. Boehringer Ingelheim Arthritis Treatment Medicine for Dogs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Boehringer Ingelheim Arthritis Treatment Medicine for Dogs Product Portfolio Table 102. Boehringer Ingelheim Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Arthritis Treatment Medicine for Dogs Distributors List Table 106. Arthritis Treatment Medicine for Dogs Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Arthritis Treatment Medicine for Dogs Product Image Figure 2. Global Arthritis Treatment Medicine for Dogs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arthritis Treatment Medicine for Dogs Market Size (2021-2032) & (US$ Million) Figure 4. Global Arthritis Treatment Medicine for Dogs Sales (2021-2032) & (K Units) Figure 5. Global Arthritis Treatment Medicine for Dogs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Arthritis Treatment Medicine for Dogs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non-Steroidal Anti-Inflammatory Drug Image Figure 9. Opioids Image Figure 10. Others Image Figure 11. Global Arthritis Treatment Medicine for Dogs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Arthritis Treatment Medicine for Dogs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Type (2021-2032) Figure 14. Global Arthritis Treatment Medicine for Dogs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Arthritis Treatment Medicine for Dogs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Image Figure 19. Global Arthritis Treatment Medicine for Dogs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Arthritis Treatment Medicine for Dogs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Arthritis Treatment Medicine for Dogs Sales Market Share by Application (2021-2032) Figure 22. Global Arthritis Treatment Medicine for Dogs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Arthritis Treatment Medicine for Dogs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Application (2021-2032) Figure 25. North America Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Arthritis Treatment Medicine for Dogs Sales Market Share by Country (2021-2032) Figure 27. U.S. Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Arthritis Treatment Medicine for Dogs Sales Market Share by Country (2021-2032) Figure 32. Germany Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Arthritis Treatment Medicine for Dogs Sales Market Share by Country (2021-2032) Figure 39. China Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales Market Share by Country (2021-2032) Figure 47. Brazil Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Arthritis Treatment Medicine for Dogs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Arthritis Treatment Medicine for Dogs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Arthritis Treatment Medicine for Dogs Revenue (2021-2032) & (US$ Million) Figure 58. North America Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Arthritis Treatment Medicine for Dogs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Arthritis Treatment Medicine for Dogs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Arthritis Treatment Medicine for Dogs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Arthritis Treatment Medicine for Dogs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Steroidal Anti-Inflammatory Drug
  • Opioids
  • Others
Applications
  • Hospital and Clinic
  • Retail
Companies covered
  • Bayer
  • Zoetis
  • VetStem
  • Vetoquinol
  • Norbrook Laboratories
  • Elanco
  • Dechra Pharmaceuticals
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Arthritis Treatment Medicine for Dogs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Arthritis Treatment Medicine for Dogs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Arthritis Treatment Medicine for Dogs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Arthritis Treatment Medicine for Dogs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Arthritis Treatment Medicine for Dogs Market Dynamics
  1. 2.1 Arthritis Treatment Medicine for Dogs Industry Trends
  2. 2.2 Arthritis Treatment Medicine for Dogs Industry Drivers
  3. 2.3 Arthritis Treatment Medicine for Dogs Industry Opportunities and Challenges
  4. 2.4 Arthritis Treatment Medicine for Dogs Industry Restraints
3 Arthritis Treatment Medicine for Dogs Market by Manufacturers
  1. 3.1 Global Arthritis Treatment Medicine for Dogs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Arthritis Treatment Medicine for Dogs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Arthritis Treatment Medicine for Dogs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Arthritis Treatment Medicine for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arthritis Treatment Medicine for Dogs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Arthritis Treatment Medicine for Dogs Manufacturers, Product Type & Application
  7. 3.7 Global Arthritis Treatment Medicine for Dogs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arthritis Treatment Medicine for Dogs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arthritis Treatment Medicine for Dogs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arthritis Treatment Medicine for Dogs Tier 1, Tier 2, and Tier 3
4 Arthritis Treatment Medicine for Dogs Market by Type
  1. 4.1 Arthritis Treatment Medicine for Dogs Type Introduction
  2. 4.1.1 Non-Steroidal Anti-Inflammatory Drug
  3. 4.1.2 Opioids
  4. 4.1.3 Others
  5. 4.2 Global Arthritis Treatment Medicine for Dogs Sales by Type
  6. 4.2.1 Global Arthritis Treatment Medicine for Dogs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Arthritis Treatment Medicine for Dogs Sales by Type (2021-2032)
  8. 4.2.3 Global Arthritis Treatment Medicine for Dogs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Arthritis Treatment Medicine for Dogs Revenue by Type
  10. 4.3.1 Global Arthritis Treatment Medicine for Dogs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Arthritis Treatment Medicine for Dogs Revenue by Type (2021-2032)
  12. 4.3.3 Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Type (2021-2032)
5 Arthritis Treatment Medicine for Dogs Market by Application
  1. 5.1 Arthritis Treatment Medicine for Dogs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail
  4. 5.2 Global Arthritis Treatment Medicine for Dogs Sales by Application
  5. 5.2.1 Global Arthritis Treatment Medicine for Dogs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Arthritis Treatment Medicine for Dogs Sales by Application (2021-2032)
  7. 5.2.3 Global Arthritis Treatment Medicine for Dogs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Arthritis Treatment Medicine for Dogs Revenue by Application
  9. 5.3.1 Global Arthritis Treatment Medicine for Dogs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Arthritis Treatment Medicine for Dogs Revenue by Application (2021-2032)
  11. 5.3.3 Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Application (2021-2032)
6 Global Arthritis Treatment Medicine for Dogs Sales by Region
  1. 6.1 Global Arthritis Treatment Medicine for Dogs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arthritis Treatment Medicine for Dogs Sales by Region (2021-2032)
  3. 6.2.1 Global Arthritis Treatment Medicine for Dogs Sales by Region (2021-2026)
  4. 6.2.2 Global Arthritis Treatment Medicine for Dogs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Arthritis Treatment Medicine for Dogs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Arthritis Treatment Medicine for Dogs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Arthritis Treatment Medicine for Dogs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Arthritis Treatment Medicine for Dogs Revenue by Region
  1. 7.1 Global Arthritis Treatment Medicine for Dogs Revenue by Region
  2. 7.1.1 Global Arthritis Treatment Medicine for Dogs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Arthritis Treatment Medicine for Dogs Revenue by Region (2021-2026)
  4. 7.1.3 Global Arthritis Treatment Medicine for Dogs Revenue by Region (2027-2032)
  5. 7.1.4 Global Arthritis Treatment Medicine for Dogs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Arthritis Treatment Medicine for Dogs Revenue (2021-2032)
  8. 7.2.2 North America Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Arthritis Treatment Medicine for Dogs Revenue (2021-2032)
  11. 7.3.2 Europe Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Arthritis Treatment Medicine for Dogs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Arthritis Treatment Medicine for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Arthritis Treatment Medicine for Dogs Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Arthritis Treatment Medicine for Dogs Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 VetStem
  14. 8.3.1 VetStem Company Information
  15. 8.3.2 VetStem Business Overview
  16. 8.3.3 VetStem Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 VetStem Arthritis Treatment Medicine for Dogs Product Portfolio
  18. 8.3.5 VetStem Recent Developments
  19. 8.4 Vetoquinol
  20. 8.4.1 Vetoquinol Company Information
  21. 8.4.2 Vetoquinol Business Overview
  22. 8.4.3 Vetoquinol Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vetoquinol Arthritis Treatment Medicine for Dogs Product Portfolio
  24. 8.4.5 Vetoquinol Recent Developments
  25. 8.5 Norbrook Laboratories
  26. 8.5.1 Norbrook Laboratories Company Information
  27. 8.5.2 Norbrook Laboratories Business Overview
  28. 8.5.3 Norbrook Laboratories Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Norbrook Laboratories Arthritis Treatment Medicine for Dogs Product Portfolio
  30. 8.5.5 Norbrook Laboratories Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Arthritis Treatment Medicine for Dogs Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 Dechra Pharmaceuticals
  38. 8.7.1 Dechra Pharmaceuticals Company Information
  39. 8.7.2 Dechra Pharmaceuticals Business Overview
  40. 8.7.3 Dechra Pharmaceuticals Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dechra Pharmaceuticals Arthritis Treatment Medicine for Dogs Product Portfolio
  42. 8.7.5 Dechra Pharmaceuticals Recent Developments
  43. 8.8 Boehringer Ingelheim
  44. 8.8.1 Boehringer Ingelheim Company Information
  45. 8.8.2 Boehringer Ingelheim Business Overview
  46. 8.8.3 Boehringer Ingelheim Arthritis Treatment Medicine for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim Arthritis Treatment Medicine for Dogs Product Portfolio
  48. 8.8.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Arthritis Treatment Medicine for Dogs Value Chain Analysis
  2. 9.1.1 Arthritis Treatment Medicine for Dogs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Arthritis Treatment Medicine for Dogs Production Mode & Process
  6. 9.2 Arthritis Treatment Medicine for Dogs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Arthritis Treatment Medicine for Dogs Distributors
  9. 9.2.3 Arthritis Treatment Medicine for Dogs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst